01 Increasing Practice of Remote Blood Collection Another emerging trend is the rise of remote collection, addressing the logistical challenges of traditional blood collection methods. Previously, patients had to visit clinics or hospitals for venipuncture, often leading to delays and inconvenience, particularly in a fast-paced environment. The growing adoption of remote and virtual collection practices is transforming the landscape of blood sample collection. For instance, in April 2024, Drawbridge Health introduced the NanoDrop Lancet, an FDA-cleared device for at-home blood sampling. This advancement allows patients to collect their own samples in a non-clinical setting, increasing convenience and reducing the need for hospital visits. This trend not only enhances the patient experience but also supports healthcare professionals in performing timely diagnostic and clinical procedures.
March 2026 Greiner Bio-One expanded production capabilities for blood collection tubes and related consumables, supporting increasing demand from clinical laboratories and healthcare providers worldwide.
November 2025 Becton, Dickinson and Company (BD) expanded manufacturing capacity for blood collection products to strengthen supply resilience and meet growing global demand from hospitals and diagnostic laboratories.
September 2025 Terumo Blood and Cell Technologies expanded its blood collection technologies through enhanced automation and digital workflow solutions for blood centers, improving operational efficiency and donor experience.
June 2025 Greiner Bio-One expanded its VACUETTE® blood collection product portfolio with new sample collection solutions designed to improve laboratory workflow efficiency and specimen quality.